{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:48:14Z","timestamp":1792806494453,"version":"4.5.0"},"reference-count":30,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2020,1,1]]},"DOI":"10.1001\/jamaoncol.2019.3985","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T18:30:56Z","timestamp":1573756256000},"page":"84","source":"Crossref","is-referenced-by-count":107,"title":["Development of Genome-Derived Tumor Type Prediction to Inform Clinical Cancer Care"],"prefix":"10.1001","volume":"6","author":[{"given":"Alexander","family":"Penson","sequence":"first","affiliation":[{"name":"Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Marie-Jos\u00e9e and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niedzica","family":"Camacho","sequence":"additional","affiliation":[{"name":"Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Marie-Jos\u00e9e and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youyun","family":"Zheng","sequence":"additional","affiliation":[{"name":"Marie-Jos\u00e9e and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Varghese","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikmat","family":"Al-Ahmadie","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedram","family":"Razavi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarat","family":"Chandarlapaty","sequence":"additional","affiliation":[{"name":"Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina E.","family":"Vallejo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efsevia","family":"Vakiani","sequence":"additional","affiliation":[{"name":"Marie-Jos\u00e9e and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Gilewski","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan E.","family":"Rosenberg","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Shady","sequence":"additional","affiliation":[{"name":"Marie-Jos\u00e9e and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana W. Y.","family":"Tsui","sequence":"additional","affiliation":[{"name":"Marie-Jos\u00e9e and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalicia N.","family":"Reales","sequence":"additional","affiliation":[{"name":"Clinical Research Administration, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Abeshouse","sequence":"additional","affiliation":[{"name":"Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Marie-Jos\u00e9e and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijazuddin","family":"Syed","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Zehir","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus","family":"Schultz","sequence":"additional","affiliation":[{"name":"Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Marie-Jos\u00e9e and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Ladanyi","sequence":"additional","affiliation":[{"name":"Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Solit","sequence":"additional","affiliation":[{"name":"Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Marie-Jos\u00e9e and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Weill Cornell Medical College, Department of Medicine, Cornell University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Klimstra","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Weill Cornell Medical College, Department of Pathology and Laboratory Medicine, Cornell University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Hyman","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Weill Cornell Medical College, Department of Medicine, Cornell University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry S.","family":"Taylor","sequence":"additional","affiliation":[{"name":"Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Marie-Jos\u00e9e and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Berger","sequence":"additional","affiliation":[{"name":"Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Marie-Jos\u00e9e and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Weill Cornell Medical College, Department of Pathology and Laboratory Medicine, Cornell University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"coi190081r1","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1056\/NEJMoa1502309","article-title":"Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 mutations.","volume":"373","author":"Hyman","year":"2015","journal-title":"N Engl J Med"},{"issue":"12","key":"coi190081r2","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1093\/annonc\/mdx545","article-title":"Clinical and molecular characterization of patients with cancer of unknown primary in the modern era.","volume":"28","author":"Varghese","year":"2017","journal-title":"Ann Oncol"},{"issue":"5439","key":"coi190081r3","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1126\/science.286.5439.531","article-title":"Molecular classification of cancer: class discovery and class prediction by gene expression monitoring.","volume":"286","author":"Golub","year":"1999","journal-title":"Science"},{"issue":"5","key":"coi190081r4","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1634\/theoncologist.2009-0328","article-title":"Molecular profiling in unknown primary cancer: accuracy of tissue of origin prediction.","volume":"15","author":"Greco","year":"2010","journal-title":"Oncologist"},{"key":"coi190081r5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12920-015-0130-0","article-title":"TumorTracer: a method to identify the tissue of origin from the somatic mutations of a tumor specimen.","volume":"8","author":"Marquard","year":"2015","journal-title":"BMC Med Genomics"},{"issue":"10","key":"coi190081r6","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/S1470-2045(16)30297-2","article-title":"Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis.","volume":"17","author":"Moran","year":"2016","journal-title":"Lancet Oncol"},{"issue":"1","key":"coi190081r7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13073-017-0493-2","article-title":"Predicting cancer type from tumour DNA signatures.","volume":"9","author":"Soh","year":"2017","journal-title":"Genome Med"},{"issue":"1","key":"coi190081r8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/path.2915","article-title":"MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin.","volume":"225","author":"Ferracin","year":"2011","journal-title":"J Pathol"},{"issue":"1","key":"coi190081r9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13059-017-1191-5","article-title":"CancerLocator: non-invasive cancer diagnosis and tissue-of-origin prediction using methylation profiles of cell-free DNA.","volume":"18","author":"Kang","year":"2017","journal-title":"Genome Biol"},{"issue":"28","key":"coi190081r10","doi-asserted-by":"publisher","first-page":"7414","DOI":"10.1073\/pnas.1703577114","article-title":"DNA methylation markers for diagnosis and prognosis of common cancers.","volume":"114","author":"Hao","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1-2","key":"coi190081r11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.cell.2015.11.050","article-title":"Cell-free DNA comprises an in vivo nucleosome footprint that informs its tissues-of-origin.","volume":"164","author":"Snyder","year":"2016","journal-title":"Cell"},{"issue":"7","key":"coi190081r12","doi-asserted-by":"publisher","first-page":"835","DOI":"10.6004\/jnccn.2015.0101","article-title":"Clinical sequencing contributes to a BRCA-associated cancer rediagnosis that guides an effective therapeutic course.","volume":"13","author":"Chapman","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"issue":"6","key":"coi190081r13","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat Med"},{"issue":"3","key":"coi190081r14","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial Sloan Kettering\u2013Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology.","volume":"17","author":"Cheng","year":"2015","journal-title":"J Mol Diagn"},{"key":"coi190081r15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forests.","volume":"45","author":"Breiman","year":"2001","journal-title":"Mach Learn"},{"issue":"4","key":"coi190081r16","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1007\/s10489-012-0388-2","article-title":"On the effect of calibration in classifier combination.","volume":"38","author":"Bella","year":"2013","journal-title":"Appl Intell"},{"issue":"2","key":"coi190081r17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nbt.3391","article-title":"Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.","volume":"34","author":"Chang","year":"2016","journal-title":"Nat Biotechnol"},{"issue":"1","key":"coi190081r18","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/s41467-017-00965-y","article-title":"Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors.","volume":"8","author":"Adalsteinsson","year":"2017","journal-title":"Nat Commun"},{"issue":"18","key":"coi190081r19","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1056\/NEJMoa1210093","article-title":"Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations.","volume":"367","author":"Flaherty","year":"2012","journal-title":"N Engl J Med"},{"issue":"20","key":"coi190081r20","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1056\/NEJMoa1406037","article-title":"Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma.","volume":"371","author":"Long","year":"2014","journal-title":"N Engl J Med"},{"issue":"20","key":"coi190081r21","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1200\/JCO.2016.66.6487","article-title":"evaluating cancer of the central nervous system through next-generation sequencing of cerebrospinal fluid.","volume":"34","author":"Pentsova","year":"2016","journal-title":"J Clin Oncol"},{"issue":"4","key":"coi190081r22","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/ng.3503","article-title":"Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer.","volume":"48","author":"Al-Ahmadie","year":"2016","journal-title":"Nat Genet"},{"issue":"4","key":"coi190081r23","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1001\/jamaoncol.2015.1313","article-title":"Whole-exome sequencing of metastatic cancer and biomarkers of treatment response.","volume":"1","author":"Beltran","year":"2015","journal-title":"JAMA Oncol"},{"issue":"19","key":"coi190081r24","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.87062","article-title":"Institutional implementation of clinical tumor profiling on an unselected cancer population.","volume":"1","author":"Sholl","year":"2016","journal-title":"JCI Insight"},{"issue":"11","key":"coi190081r25","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1634\/theoncologist.2016-0049","article-title":"Clinical actionability of comprehensive genomic profiling for management of rare or refractory cancers.","volume":"21","author":"Hirshfield","year":"2016","journal-title":"Oncologist"},{"issue":"11","key":"coi190081r26","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/nbt.2696","article-title":"Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing.","volume":"31","author":"Frampton","year":"2013","journal-title":"Nat Biotechnol"},{"issue":"111","key":"coi190081r27","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003161","article-title":"Personalized oncology through integrative high-throughput sequencing: a pilot study.","volume":"3","author":"Roychowdhury","year":"2011","journal-title":"Sci Transl Med"},{"issue":"5","key":"coi190081r28","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jmoldx.2013.05.003","article-title":"Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes.","volume":"15","author":"Singh","year":"2013","journal-title":"J Mol Diagn"},{"issue":"1","key":"coi190081r29","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","article-title":"High-performance medicine: the convergence of human and artificial intelligence.","volume":"25","author":"Topol","year":"2019","journal-title":"Nat Med"},{"issue":"21","key":"coi190081r30","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1001\/jama.2018.17163","article-title":"Clinical decision support in the era of artificial intelligence.","volume":"320","author":"Shortliffe","year":"2018","journal-title":"JAMA"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2755639\/jamaoncology_penson_2019_oi_190081.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T16:01:21Z","timestamp":1578585681000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2755639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2019.3985","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1,1]]}}}